Combination therapy for proliferative disorders

Details Combination therapy for proliferative disorders Combination therapy for proliferative disorders

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/337 (2006.01) A61K 31/366 (2006.01) A61K 31/437 (2006.01) A61K 31/519 (2006.01) A61K 31/7088 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2669982

The present invention provides compositions and methods of treating proliferative disorders using combination therapy with a first agent that specifically inhibits DNA polymerase alpha and a second agent that inhibits protein kinases, such as Chk1.

La présente invention propose des compositions et des procédés de traitement de troubles prolifératifs en utilisant une thérapie combinée, un premier agent inhibant spécifiquement l'ADN polymérase alpha et un second agent inhibant des protéines kinases, telles que Chk1.

Affiliated with

Also associated with

Rating

Combination therapy for proliferative disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for proliferative disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for proliferative disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1760592